Literature DB >> 25311001

Recent development in [1,4]benzodiazepines as potent anticancer agents: a review.

Rupinder Kaur Gill, Shiv Om Kaushik, Jasreen Chugh, Sumit Bansal, Anamik Shah, Jitender Bariwal1.   

Abstract

The [1,4]benzodiazepine is an important class of heterocyclic compounds and clinically used for many ailments in humans. The [1,4]benzodiazepine has unique structure that mimics the peptide linkage. This interesting observation completely shifted the interest of medicinal chemist for [1,4]benzodiazepine from CNS acting drugs to anticancer agents. During last few decades, a large number of reports have appeared in the literature highlighting the anticancer activity of [1,4]benzodiazepines. Here, in this article, we have discussed the brief synthesis, origin of [1,4]benzodiazepines as anticancer agent, their mechanism of action and latest developments in this field. We have compiled the most important literature reports from last few decades till date.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25311001     DOI: 10.2174/13895575113139990081

Source DB:  PubMed          Journal:  Mini Rev Med Chem        ISSN: 1389-5575            Impact factor:   3.862


  2 in total

1.  Sequential Ugi reaction/base-induced ring closing/IAAC protocol toward triazolobenzodiazepine-fused diketopiperazines and hydantoins.

Authors:  Robby Vroemans; Fante Bamba; Jonas Winters; Joice Thomas; Jeroen Jacobs; Luc Van Meervelt; Jubi John; Wim Dehaen
Journal:  Beilstein J Org Chem       Date:  2018-03-14       Impact factor: 2.883

2.  Stereoselective Olefination with Sterically Demanding Julia-Kocienski Reagents: Total Synthesis of Oxo-prothracarcin, Oxo-tomaymycin, and Boseongazepine B.

Authors:  Zigma Rs Leitis; Guna Sakaine; Artis Kine Ns; Gints Smits
Journal:  ACS Omega       Date:  2022-08-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.